Skip to content
Dr. Dionysis Papadatos-Pastos: London Chest and Lung SurgeonDr. Dionysis Papadatos-Pastos: London Chest and Lung Surgeon
  • Home
  • About
  • Lung Cancer
    • Non-Small Cell Lung Cancer
    • Small Cell Lung Cancer
    • The lung cancer diagnostic pathway
    • Oligometastatic Lung Cancer in 2025
    • MET-Driven Lung Cancer: Insights and Advances
  • Mesothelioma
    • Mesothelioma
    • Mesothelioma diagnostic pathway
  • Thymic tumors
  • Clinics
    • In-Person Consultation
    • Video Consultation
    • A Guide for New Patients
  • Contact
Media

To intensify or not to intensify 1L treatment in EGFR-Mutated NSCLC?

Resources for physicians:

Dr Papadatos-Pastos presentation on 1st line treatment for EGFR driven non small cell lung cancer

https://www.vumedi.com/video/optimizing-treatment-intensification-in-1l-egfr-mutated-nsclc/

Requires registration in vumedi

To intensify or not to intensify 1L treatment in EGFR-Mutated NSCLC?
Dr Papadatos-Pastos in the Evening Standard (10 September 2024)
Discussing Antibody Drug Conjugates in NSCLC

Dedicated to providing compassionate, comprehensive cancer care tailored to meet the patient's expectations.

Call us E-mail

Reviews

Content

  • Home
  • About
  • Non-Small Cell Lung Cancer
  • Small Cell Lung Cancer
  • Mesothelioma
  • Thymic tumors
  • Clinics

Contact

Mori Heydari and Susanne Proudfoot

116 Harley Street London W1G 7JL

  • 020 7616 7667
  • Enquiries@oncologist.london

© 2025 Dr Dionysis Papadatos-Pastos
Website design: insert.gr

Terms Privacy Cookies
  • Home
  • About
  • Lung Cancer
    • Non-Small Cell Lung Cancer
    • Small Cell Lung Cancer
    • The lung cancer diagnostic pathway
    • Oligometastatic Lung Cancer in 2025
    • MET-Driven Lung Cancer: Insights and Advances
  • Mesothelioma
    • Mesothelioma
    • Mesothelioma diagnostic pathway
  • Thymic tumors
  • Clinics
    • In-Person Consultation
    • Video Consultation
    • A Guide for New Patients
  • Contact